Purpose To analyse high-molecular-weight matrix glycoproteins in trabecular meshwork, cornea and sclera using SDS/P AGE and immuno-and lectin blotting. 
and adhesion, together with stabilisation of the ECM, are mediated through specialised and unique domains on ECM molecules. Matrix glycoproteins (GP) of the TM with known binding sites for ECM components and the cell surface include fibronectin (FN)3-6 and type VI collagen?-lO These GP are also found in comea and sclera -tissues that show very different physical properties and functions whilst sharing many of the same matrix componentsY FN binds with high affinity to cell surfaces, collagens and proteoglycans and mediates the attachment of cells to basement membranes and ECM. In the TM it is secreted by TM cells12 and has been localised on trabecular beams by immunocytochemical methods. 13 In cornea, FN has been localised in epithelial basement membrane, stroma and Descemet's membrane. 14 Type VI collagen is a microfibrillar protein that interacts with cells and ECM, 8,9,15.16 where it forms extensive networks.17,18 Type VI collagen is heterotrimeric, consisting of three genetically distinct a chains, where the molecular mass of each of the 0'1 and u2 chains is 140 kDa, and that of the u3 chains is �200 kDa (using non-collagenous standards ).18-2 0 Type VI collagen is believed to play a key role in the maintenance of connective tissue and an age-related increase in a 140 kDa protein in TM extracts has been demonstrated on polyacrylamide gel electrophoresis (P AGE)?1 Subsequently, immunoblotting identified the 140 kDa protein as u1 / u2 chains of type VI collagen [0'1/0'2 (VI)]. 22 It has also been identified immunocytochemically in normal TM. 23 Type VI collagen forms a major constituent of human cornea24 and promotes adhesion and spreading of corneal fibroblasts. 25 The characteristics and function of GP depend on the nature of the glycan component, so that altered glycosylation states can affect cell-matrix and matrix-matrix interactions. The microfibrillar structure of type VI collagen is believed to be due, in part, to the glycosylation of helical domains26 where lateral aggregation is restricted, and it is known that the glycans of type VI collagen and FN include complex N linked and O-linked saccharides?6,27 In a lectin Eye (1998) 12, 440-448 © 1998 Royal College of Ophthalmologists .. 1 TM28 histochemical study of glycan expresslOn m norma we localised high mannose, complex N-linked, bisected and non-bisected bi / tri-antennate glycans on Schlemm's canal endothelium and, to a lesser extent, on trabecular cells and in the cores of trabecular beams. N-acetyl lactosamine and O-linked sequences were also identified. When compared with glycan expression in glaucomatous TM29 we observed a decrease in some N-linked glycans as shown by binding of PSA (Pisum sativum agglutinin). O-linked glycans, as shown by binding of MP A (Madura pomifera agglutinin), and N-acetyl glucosamine oligomers, as indicated by DSA (Datura stramonium agglutinin), were significantly increased. The associated CP were not identified.
In this preliminary report we have analysed tissue extracts from normal TM, cornea and sclera using PACE and Western blotting. Blots were stained for total protein and immunoblotted with anti-FN antibody and anti-type VI collagen antibody. Lectin blotting with PSA, MP A and DSA localised some of the glycans present to bands corresponding to the identified GP.
Materials and methods

Tissue
Normal TM was obtained from six whole globes, with no ocular pathology. Two of these were taken at autopsy within 12 h of death (ages 70 and 79 years). Four were obtained from orbital exenteration procedures for sebaceous carcinoma of the eyelid (ages 76, 85 and 68 years) and lacrimal gland carcinoma (age 84 years) where there was no ocular involvement. Cornea and sclera were also acquired from three of these eyes. Normal TM, cornea and sclera from seven time-expired corneas (age range 65-96 years) were obtained from the Eye Bank, Royal Eye Hospital, Manchester.
Preparation of tissue
Normal TM was excised from the three whole globes by one of two methods. After cutting the eye at the ora serrata and removing the lens, the cornea was positioned resting on the anterior surface and cut radially into segments. The tissue was immediately frozen and stored at -70 DC. The TM was readily dissected away from the sclera and cornea by use of a dissecting microscope after thawing, as required. In the second method30 the attachments of the ciliary body were severed, and clean partial-thickness cuts were made in front of the scleral spur and behind Schwalbe's line. The TM could then be removed with fine forceps and pulled away, prior to freezing and storage at -70 DC.
The time-expired corneas included a rim of sclera and TM. After removing the TM with fine forceps, pieces of sclera and cornea (approx. 
Tissue extraction
The GP were extracted from TM, cornea and sclera by adapting a method described previously.21 Briefly, following two washes with PBS pH 7.4, whole TM was extracted into 200 J.Ll of buffer containing 0.0625 M Tris
0.02% (w / v) bromophenol blue, and heated at 100 DC for 5 min. Following centrifugation at 13 000 g for 15 min, the supernatant was removed, the pellet extracted again with the same volume of buffer and the combined supernatants stored at -20 DC. The cornea and scleral tissues were cut into pieces measuring approXimately 2 X 1 X 1 mm and washed twice with PBS. Each tissue fragment was extracted twice with a volume of sample buffer equivalent to 25 J.Ll for each piece of tissue and the tissue extracts were pooled.
Protein concentration was estimated using a comparative dot-blotting technique with known concentrations of prepared standard solutions of bovine serum albumin (BSA). The dot-blotted proteins were visualised using Protogold, a colloidal gold sol that binds quantitatively to proteins blotted onto a membrane. The method used was that recommended by the manufacturers (British Biocell). The colour intensity of the dots was compared visually with that of the standards to give an approximate value of protein concentration.
Gel electrophoresis
The tissue extracts from individual eyes were each investigated separately and, where possible, extracts of TM, cornea and sclera from each eye were analysed on the same gel.
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200
Lectin specificity
The specificity of the lectin binding was confirmed by incubating the lectin with the appropriate inhibiting sugar prior to lectin blotting. PSA (major specificity (X-D-mannose in non-bisected bi! tri-antennary N-linked inhibited lectins were each used in a parallel lane and compared with the uninhibited lectin on the same blot.
Results
Total protein staining
The extractions from TM, cornea and sclera with 50S/ urea and OTT on 4-20% graduated gels produced major high-molecular-weight bands at -240, 180-200, 125-130 and 66 kOa, together with numerous other faster- migrating bands. The pattern of major bands produced on analysis of each tissue was the same in individual eyes, with some minor variations in the relative intensities of individual bands. A band at -100 kDa, together with other less distinct bands, was also observed in extractions from normal TM (Fig. 1) . When a 6.5% PAGE gel was used, two bands at 140 and 130 kDa were seen in cornea and sclera (Fig. 2) . Molecular weight estimation of GP on SDS/PAGE is more accurate on gradient gels than on uniform gels; the latter tend to overestimate molecular weight because of the glycan content in the GP. It was assumed that the 125-130 kDa component on 4-20% gradient gels is the same as the 140 kDa component on a 6.5% gel.
The main differences observed between the extracts of TM, sclera and cornea were as follows: The single band at �200 kDa in normal TM was seen as a doublet or as multiple bands in cornea and sclera (Figs. 1, 2) . The 140 kDa band in cornea and sclera was relatively stronger than the corresponding band in normal TM. A band at -30 kDa was variable in intensity and was seen prominently in some extracts of sclera, but much less so in others.
Immunoblotting
Anti-FN antibody bound to the 240 kDa band in normal TM, cornea and sclera (Fig. 3 ) and was sometimes seen as a doublet (Fig. 4) . The control was negative. The antibody bound extensively to the FN standard and degradation products. The VIB collagen antibody, with principal specificity for the a3 (VI) chain, bound to three bands at �200 kDa in normal TM (Figs. 5, 6a) . In six of the normal TMs the antibody binding was much stronger to one of the bands compared with the other two (Fig. 5) . A prominent band in the same position was observed on blots of normal TM that were stained for total protein.
Extracts of cornea and sclera from the same eyes (on the same blot), showed a ladder of four closely spaced bands at �200 kDa (Figs. 5, 6a ). Fig. 6b shows an immunoblot of the type VI collagen-containing extract and the VIB antibody where the four components are visible. Extracts of TM, cornea and sclera from one eye also each showed a band at � 140 kDa, with a slightly differing mobility, that was immunoreactive with both type VI collagen antibodies (Fig. 6a) . The VIG antibody with specificity for a1a2 (VI) bound to the 140 kDa component in TM, cornea and sclera (Fig. 6a) .
Lectin blotting
The binding specificity of the lectins was confirmed by the inhibition experiments, in which the binding of PSA and DSA was totally eliminated and that of MP A was very much reduced. Replacement of the lectin with saline gave a negative result with gold-labelled antibiotin. PSA and MP A binding were in general better defined than that of DSA, which was more diffuse. The results of lectin blotting are summarised in Table 1 . An example of lectin blotting of TM, cornea and sclera is shown in Fig. 7 .
Normal TM kDa that bound this lectin (Fig. 7b) .
Discussion
We have investigated the higher-molecular-weight components extracted by SDS / urea from TM, cornea and sclera. The component at 240 kDa, which was seen in normal TM, cornea and sclera was identified as FN on the basis of the immunoblotting results with an FN We have demonstrated by immunoblotting that, in reduced extracts of normal TM, the prominent band at �200 kDa is the a3 (VI) chain. The ladder of bands in the range 180-240 kDa, which is visible in corneal and scleral extracts and binds anti-type VI antibody, is characteristic of the a3 (VI) chain and has been reported in type VI collagen extracts from numerous other tissues?O, 35 The band at �140 kDa on 6.5% gels (125-130 kDa on 4-20% gels) observed in extracts of TM, cornea and sclera is identified as the co-migrating a1 / a2 (VI) chains. Each of the three genetically distinct a chains consists of a short triple helical region with large N-and C-terminal globular domains. 19 The globular domains consist of repetitive sub-domains, and alternative splicing can occur in the C-terminal end of the a2 (VI) chain and in at least four subdomains of the N-terminal domain of the a3 (VI) chain?6.38
The ladder of bands observed in the type VI collagen standard and corneal and scleral extracts is therefore identified as the alternatively spliced forms of the a3 (VI) chain. It appears that they are produced in different proportions in normal TM, cornea and sclera, with normal TM producing relatively more of one variant, observed as a prominent band at �200 kDa in blots of TM extractions stained for total protein. Two of the domains include cysteine residues and potential N glycosylation sites, and hence alternative splicing could affect protein folding and function?9 It may also affect the microfibrillar structure of type VI collagen and, thereby, the characteristics of the extracellular matrix. The a3 (VI) chain is thought to have a crucial role in its assembly and tissue deposition. Transforming growth factor beta (TGF-I3) causes a selective increase in a3 (VI) mRNA and an increased secretion of collagen Vr.40 As TGF-13 is known to be increased in aqueous humour in POAG4I it is possible that the differential expression of a3 (VI) may be involved in the pathogenesis of this condition. Type VI collagen is believed to show an age related increase in the TM but this has not been positively linked with the increase in 'long-spacing' (100 nm) that is observed in POAG TM. An immunogold study at the ultrastructural level localised type VI collagen to the 'long-spacing' collagen in glaucomatous TM,42 but this was not confirmed in a later report, where it was identified in the fine network of trabecular cores and the juxta canalicular network. 11 Type VI collagen is a major component of cornea24 and has been localised immunocytochemically at the ultrastructural level in epithelial basement membrane, stroma and Descemet's membrane, though not in the 'long-spacing' collagen.43 It is also one of the components of the interfibrillar matrix in sclera. 44 The binding of PSA, DSA and MP A to FN of TM, cornea and sclera indicates the presence of complex, bi/ tri-antennary N-linked glycans and some O-linked glycans. This concurs with reports of known carbohydrates in human FN which, depending on the tissue source, contain bi-or tri-antennary groups. The complex N-linked glycans identified on the 0:3 chains of type VI collagen are linked to asparagine residues in the triple helix where two potential N-linked acceptor sites are fully occupied26 or to sites in the globular domain. The O-linked glycosides of the triple helix of VI collagen are linked to hydroxylysine and not to serine or threonine?6 Since MP A binds only to glycans that are 0-linked via serine or threonine, it is probably binding to sites on the globular domains of the 0:3 (VI) chain in TM, cornea and sclera. MPA binding to the component at 140 kDa in normal TM suggests that O-linked glycans are also present in the globular domains of the 0:1/0:2 (VI) chains. These glycans are not present (or not available) in cornea and sclera, where MP A binds to a faster component.
Conclusion
Collagen VI isoforms in TM appear to differ in two respects from those of cornea and sclera. TM produces relatively more of one variant of the 0:3 (VI) chain, whereas cornea and sclera express all four variants in apparently similar proportions. There appears to be a greater availability of O-linked Gal on the 0:1/0:2 (VI) chains of TM than in cornea and sclera. The variation in the expression of type VI collagen isoforms in TM compared with cornea and sclera may be a reflection of the function of type VI collagen in these tissues.
